In this episode, J.D. and Kerri discuss the bill that passed in the House last week focused on provisions related to the affordable care act and prescription drug pricing. They also tackle surprise medical billing, baseball-style arbitration and the (other) tv series finale that happened in the last week. 

Health care has been a hot topic over the past week in Washington. In this special edition episode, J.D. and Kerri break down what you need to know about health care reform legislation events from the past week. 

As we reached the 9th anniversary of the Affordable Care Act just days ago, J.D. and Kerri discuss the 8 separate healthcare bills that have been proposed in recent months. These bills range from Medicare-for-all to incremental approaches to universal healthcare.  Hear what this could mean for employer-sponsored benefits, prescription drug costs and more in the latest episode. 

Health care costs are expected to continue accelerating over the next several years, and there are policies on the table to try and reduce the impact. One area of focus is further regulating prescription drug costs through rebate changes and a stronger push towards generic over name-brand pharmaceuticals. This and more (including J.D. and Kerri’s Oscar picks) in the latest episode. 

In this episode, J.D. Piro and Kerri Willis discuss Medicare-for-All, the Affordable Care Act and what to expect in 2019. 

The results of the mid-term election are in and the Democratic Party has regained control of the House. Aon Health & Benefits consultants J.D. Piro and Kerri Willis give a sneak peak of their full-length webinar, as they discuss the implications of the mid-term election results on health care reform.